Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 125
Single User License Price INR 9046
Corporate User License Price USD 375
Corporate User License Price INR 27139
Site License Price USD 250
Site License Price INR 18093
Request a Quote

Report Title

Proteostasis Therapeutics Inc (PTI) - Financial and Strategic SWOT Analysis Review

Quote Request for License Type
License Type Price  
Single User License USD 125
Site License USD 250
Enterprise Wide License USD 375
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Proteostasis Therapeutics Inc (PTI) - Financial and Strategic SWOT Analysis Review


Quote Request for License Type
License Type Price  
Single User License USD 125
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Proteostasis Therapeutics Inc (PTI) - Financial and Strategic SWOT Analysis Review

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Proteostasis Therapeutics Inc (PTI) - Financial and Strategic SWOT Analysis Review



Executive Summary

Proteostasis Therapeutics Inc (PTI)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Proteostasis Therapeutics Inc (Proteostasis) is a developer of therapies that discovers and develops therapeutics for the treatment of diseases related to defects in protein folding, trafficking and clearance. The company's portfolio spans drug candidates for cystic fibrosis, neurodegeneration and protein conformational diseases. Proteostasis employs Disease Relevant Translation platform that combines proteomics, genomics, and functional assays with medicinal chemistry and systems biology to discover novel drugs for disorders such as Alzheimer's disease, Huntington's disease, and Parkinson's disease. PTI is headquartered in Cambridge, Massachusetts, the US.

Proteostasis Therapeutics Inc Key Recent Developments

Mar 14,2018: Proteostasis Therapeutics Announces Fourth Quarter and Year-End 2017 Financial Results

Nov 14,2017: Proteostasis Therapeutics Reports Third Quarter 2017 Results and Provides CF Portfolio Update

Oct 31,2017: Proteostasis Therapeutics Focuses on Research and Development of CF Drug Candidates and Astellas Pharma Collaboration Programs

Jul 31,2017: Proteostasis Appoints Helen M. Boudreau as Chief Financial Officer

Jul 31,2017: Proteostasis Therapeutics names Helen M. Boudreau as CFO

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1-About the Company 5

Proteostasis Therapeutics Inc-Key Facts 5

Proteostasis Therapeutics Inc-Key Employees 6

Proteostasis Therapeutics Inc-Key Employee Biographies 7

Proteostasis Therapeutics Inc-Major Products and Services 9

Proteostasis Therapeutics Inc-History 10

Proteostasis Therapeutics Inc-Company Statement 13

Proteostasis Therapeutics Inc-Locations And Subsidiaries 17

Head Office 17

Section 2-Company Analysis 18

Company Overview 18

Proteostasis Therapeutics Inc-Business Description 19

R&D Overview 19

Proteostasis Therapeutics Inc-Corporate Strategy 20

Proteostasis Therapeutics Inc-SWOT Analysis 21

SWOT Analysis-Overview 21

Proteostasis Therapeutics Inc-Strengths 21

Proteostasis Therapeutics Inc-Weaknesses 22

Proteostasis Therapeutics Inc-Opportunities 23

Proteostasis Therapeutics Inc-Threats 24

Proteostasis Therapeutics Inc-Key Competitors 25

Section 3-Company Financial Ratios 26

Financial Ratios-Capital Market Ratios 26

Financial Ratios-Annual Ratios 27

Performance Chart 29

Financial Performance 29

Financial Ratios-Interim Ratios 30

Financial Ratios-Ratio Charts 31

Section 4-Company's Lifesciences Financial Deals and Alliances 32

Proteostasis Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 32

Proteostasis Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 33

Proteostasis Therapeutics Inc, Recent Deals Summary 34

Section 5-Company's Recent Developments 35

Nov 14, 2017: Proteostasis Therapeutics Reports Third Quarter 2017 Results and Provides CF Portfolio Update 35

Oct 31, 2017: Proteostasis Therapeutics Focuses on Research and Development of CF Drug Candidates and Astellas Pharma Collaboration Programs 37

Jul 31, 2017: Proteostasis Appoints Helen M. Boudreau as Chief Financial Officer 38

Jun 02, 2017: Basilea names new member of its Extended Management Committee 39

Mar 30, 2017: Proteostasis Therapeutics Reports Fourth Quarter and Year-End 2016 Financial Results and Provides Corporate Update 40

Feb 27, 2017: Basilea proposes Dr. Nicole Onetto as new member of the Board of Directors 42

Feb 27, 2017: Basilea proposes Dr. Nicole Onetto as new member of the Board of Directors 43

Section 6-Appendix 44

Methodology 44

Ratio Definitions 44

About GlobalData 48

Contact Us 48

Disclaimer 48

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Figures

Proteostasis Therapeutics Inc, Performance Chart (2013-2017) 29

Proteostasis Therapeutics Inc, Ratio Charts 31

Proteostasis Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 32

Proteostasis Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 33

List of Tables

Proteostasis Therapeutics Inc, Key Facts 5

Proteostasis Therapeutics Inc, Key Employees 6

Proteostasis Therapeutics Inc, Key Employee Biographies 7

Proteostasis Therapeutics Inc, Major Products and Services 9

Proteostasis Therapeutics Inc, History 10

Proteostasis Therapeutics Inc, Key Competitors 25

Proteostasis Therapeutics Inc, Ratios based on current share price 26

Proteostasis Therapeutics Inc, Annual Ratios 27

Proteostasis Therapeutics Inc, Annual Ratios (Cont...1) 28

Proteostasis Therapeutics Inc, Interim Ratios 30

Proteostasis Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 32

Proteostasis Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 33

Proteostasis Therapeutics Inc, Recent Deals Summary 34

Currency Codes 44

Capital Market Ratios 44

Equity Ratios 45

Profitability Ratios 45

Cost Ratios 46

Liquidity Ratios 46

Leverage Ratios 47

Efficiency Ratios 47

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

ProQR Therapeutics B.V.

IsoRay Inc

AbbVie Inc

Flatley Discovery Lab

Galapagos NV

Vertex

Proteostasis Therapeutics Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand